Skip to main content
Austin Anderson, DO, Rheumatology, Silver Spring, MD

AustinAndersonDO

Rheumatology Silver Spring, MD

Medical Officer, Division of Rheumatology and Transplant Medicine, FDA

Dr. Anderson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Anderson's full profile

Already have an account?

  • Office

    10903 New Hampshire Ave
    Silver Spring, MD 20993

Summary

  • Dr. Anderson is a Rheumatologist and Medical Officer in the Division of Rheumatology and Transplant Medicine at the U.S. Food and Drug Administration (FDA). Prior to joining the FDA, he was an Assistant Professor of Medicine in the Division of Rheumatology and Clinical Immunology at the University of Florida.

Education & Training

  • University of Florida
    University of FloridaFellowship, Rheumatology, 2017 - 2019
  • University of Florida
    University of FloridaResidency, Internal Medicine, 2014 - 2017
  • University of Florida
    University of FloridaInternship, Internal Medicine, 2014 - 2015
  • Philadelphia College of Osteopathic Medicine
    Philadelphia College of Osteopathic MedicineClass of 2014

Certifications & Licensure

  • MD State Medical License
    MD State License 2019 - 2026
  • FL State Medical License
    FL State License 2019 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology
  • International Society of Clinical Densitometry Certified Clinical Densitometrist

Awards, Honors, & Recognition

  • FDA Honor Award Recepient U.S. Food and Drug Administration, 2023
  • Resident of the Month University of Florida Shands Hospital, 2017
  • Key Award University of Florida Shands Hospital, 2016

Publications & Presentations

PubMed

Books/Book Chapters

Lectures

  • Emerging Use of Artificial Intelligence in Drug Development 
    American College of Rheumatology Convergence 2024 - 11/16/2024

Press Mentions

  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases
    FDA Gives Updates on Newly Approved Agents for Rheumatic DiseasesNovember 17th, 2024
  • FDA to Review New Rheumatology Approvals, Safety Messaging, Programs
    FDA to Review New Rheumatology Approvals, Safety Messaging, ProgramsNovember 8th, 2024